Ju Bo Liu
Directeur/Bestuurslid bij BIOTON S.A.
Actieve functies van Ju Bo Liu
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
BIOTON S.A. | Directeur/Bestuurslid | 01-01-2022 | - |
NovoTek Pharmaceuticals Ltd.
NovoTek Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Yifan Pharmaceutical Co., Ltd., NovoTek Pharmaceuticals Ltd. is a Chinese pharmaceutical company that manufactures pharmaceutical products. The company is based in Hong Kong, Hong Kong. The company was founded by Ju Bo Liu. Ju Bo Liu has been the CEO since incorporation. NovoTek Pharmaceuticals was acquired by Yifan International Pharmaceutical Co., Ltd. from Merrylake International Ltd. on January 25, 2018 for $20.60 million. | Algemeen Directeur | - | - |
Oprichter | - | - | |
Novotek Medicinal Technology Development Co. Ltd. | Algemeen Directeur | 01-08-2009 | - |
Beijing Novotek Medicinal Technology Development Co. Ltd. | Algemeen Directeur | 01-09-2009 | - |
Oprichter | 01-09-2009 | - | |
Itabmed Co., Ltd.
Itabmed Co., Ltd. BiotechnologyHealth Technology ITabMed Co., Ltd. is a Chinese clinical-stage biotech company that focuses on the discovery and development of immunotherapy products to treat cancer. The company is based in Shanghai, China. ITabMed Co. was founded in 2020 by Xiaoqiang Yan, who has been the CEO since 2020. | Directeur/Bestuurslid | - | - |
Loopbaan van Ju Bo Liu
Eerdere bekende functies van Ju Bo Liu
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
SCIGEN LIMITED | Directeur/Bestuurslid | 10-02-2017 | 07-08-2018 |
NovoTek Therapeutics, Inc. | Algemeen Directeur | 01-08-2009 | 01-03-2018 |
Huayuanlong Medicinal Technology Development Co. Ltd. | Algemeen Adviseur | 01-08-1997 | 01-02-2001 |
Verkoop & Marketing | 01-08-1997 | 01-02-2001 |
Opleiding van Ju Bo Liu
Shenyang Pharmaceutical University | Undergraduate Degree |
University of Toronto | Doctorate Degree |
Statistieken
Internationaal
China | 7 |
Polen | 2 |
Hongkong | 2 |
Operationeel
Chief Executive Officer | 4 |
Director/Board Member | 3 |
Founder | 3 |
Sectoraal
Health Technology | 5 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
BIOTON S.A. | Health Technology |
Bedrijven in privébezit | 7 |
---|---|
NovoTek Pharmaceuticals Ltd.
NovoTek Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Yifan Pharmaceutical Co., Ltd., NovoTek Pharmaceuticals Ltd. is a Chinese pharmaceutical company that manufactures pharmaceutical products. The company is based in Hong Kong, Hong Kong. The company was founded by Ju Bo Liu. Ju Bo Liu has been the CEO since incorporation. NovoTek Pharmaceuticals was acquired by Yifan International Pharmaceutical Co., Ltd. from Merrylake International Ltd. on January 25, 2018 for $20.60 million. | Health Technology |
Novotek Medicinal Technology Development Co. Ltd. | |
Huayuanlong Medicinal Technology Development Co. Ltd. | |
SciGen Pte Ltd.
SciGen Pte Ltd. Pharmaceuticals: MajorHealth Technology SciGen Pte Ltd. engages in the development, manufacturing, and marketing of biopharmaceutical products. It operates through following segments: Singapore, Australia, Korea, Thailand, Philippines, China, and Others. The Singapore segment comprises of corporate office functions, sales, and marketing. The Australia, Korea, Thailand, and Philippines segments deal with sales and marketing activities. The China segment is involved in regulatory activities. The Others segment covers operations on in Indonesia, Pakistan, Vietnam, Hong Kong, Myanmar, Malaysia, and profit sharing income on sale of insulin. The firm's products include SciLin, SciTropin A, SciLocyte, SciTrace 5 Injection, and Heri Injection. The company was founded by Saul Akerib Mashaal in 1988 and is headquartered in Singapore. | Health Technology |
Beijing Novotek Medicinal Technology Development Co. Ltd. | |
NovoTek Therapeutics, Inc. | |
Itabmed Co., Ltd.
Itabmed Co., Ltd. BiotechnologyHealth Technology ITabMed Co., Ltd. is a Chinese clinical-stage biotech company that focuses on the discovery and development of immunotherapy products to treat cancer. The company is based in Shanghai, China. ITabMed Co. was founded in 2020 by Xiaoqiang Yan, who has been the CEO since 2020. | Health Technology |